Atlas Trials

Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease

Clinical trial NCT06422208 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06422208
Sponsor
Penelope J. Hallett, Ph.D.
Status
ENROLLING_BY_INVITATION
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2024-08-07
Primary completion
2026-12-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.